Search

Author/Creator D'Andrea, Alan D

1. Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial. Issue 7 (July 2020)

Authors:
Konstantinopoulos, Panagiotis A; Cheng, Su-Chun; Wahner Hendrickson, Andrea E; Penson, Richard T; Schumer, Susan T; Doyle, L Austin; Lee, Elizabeth K; Kohn, Elise C; Duska, Linda R; Crispens, Marta A; Olawaiye, Alexander B; Winer, Ira S; Barroilhet, Lisa M; Fu, Siqing; McHale, Michael T; Schilder...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 7(2020)
Page Start:
957
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. Issue 4 (April 2019)

Authors:
Konstantinopoulos, Panagiotis A; Barry, William T; Birrer, Michael; Westin, Shannon N; Cadoo, Karen A; Shapiro, Geoffrey I; Mayer, Erica L; O'Cearbhaill, Roisin E; Coleman, Robert L; Kochupurakkal, Bose; Whalen, Christin; Curtis, Jennifer; Farooq, Sarah; Luo, Weixiu; Eismann, Julia; Buss, Mary K;...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 4(2019)
Page Start:
570
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search